• TRIB3, Ferroptosis, and Sunitinib Sensitivity in ccRCC

  2026-08-21

  A 2024 Cellular Signalling study identifies TRIB3 knockdown as a strategy for increasing clear cell renal cell carcinoma sensitivity to Sunitinib. The work links TRIB3 depletion to ferroptosis through the SLC7A11/GPX4 antioxidant axis, providing a mechanistic framework for studying resistance beyond conventional RTK signaling.

• MEDUSA Reveals Hidden Drug-Death Mechanisms

  2026-08-21

  Honeywell and colleagues introduce MEDUSA, a time-resolved modeling framework that separates drug-induced growth inhibition from cell death in pooled functional genomic screens. Applied to DNA damage responses, the method shows that p53 loss can redirect lethality from apoptosis toward a respiration-dependent nonapoptotic process, offering a stronger basis for interpreting resistance and combination strategies.

• Perospirone (SM-9018 freebase): Assay Guide

  2026-08-20

  This scenario-based guide explains how Perospirone (SM-9018 freebase), SKU BA5009, can be incorporated into viability, proliferation, receptor, and vascular ion-channel experiments. It emphasizes solvent compatibility, concentration design, controls, and interpretation of neurovascular findings without treating one assay endpoint as a complete mechanism.

• Biotin for STING Assays and Protein Labeling

  2026-08-20

  Biotin (Vitamin B7) connects cofactor biology with high-sensitivity molecular detection, from carboxylase assays to streptavidin-enabled analysis of antiviral signaling. This guide shows how to adapt biotinylation workflows for STING-pathway experiments while avoiding solubility, background, and labeling-specific failure modes.

• AP20187: Reliable Cell Assay Workflows

  2026-08-19

  A scenario-driven guide to using AP20187 (SKU B1274) as a chemical inducer of dimerization in cell viability, proliferation, and cytotoxicity workflows. It connects formulation, controls, protocol optimization, interpretation, and vendor-selection decisions to practical laboratory needs.

• ABT-199 and the Logic of Mitochondrial Cell Death

  2026-08-19

  ABT-199 (Venetoclax) offers a precise way to interrogate BCL-2-dependent survival in hematologic malignancy models. This article connects its mitochondrial selectivity with a recent Pol II-degradation study to improve causal interpretation in apoptosis assays.

• AG-126: Mapping ERK Signals in D2-MSN Research

  2026-08-18

  AG-126 (Tyrphostin AG-126) provides a pharmacological way to test ERK1/2 involvement in striatal D2-MSN phenotypes. This article presents an evidence-aware assay strategy that separates ERK signaling from the PKC and circuit mechanisms identified in recent Neuroligin 1 research.

• Vernakalant Hydrochloride Research Workflows

  2026-08-18

  Build atrial-selective electrophysiology and cardioversion studies around Vernakalant Hydrochloride (RSD1235), from ion-channel assays to translational AF models. Practical concentration, handling, controls, and troubleshooting guidance help distinguish true frequency-dependent pharmacology from assay artifacts.

• A40926 Workflow for Antibacterial Research

  2026-08-17

  A40926 is a dalbavancin precursor that links mechanistic cell-wall studies with practical antibacterial screening. This guide shows how to build reproducible assays, investigate MRSA and Neisseria gonorrhoeae inhibition, and use pathway-regulator insights to improve production workflows.

• JAK Inhibitors and Endothelial Cardiovascular Risk

  2026-08-17

  A 2025 comparative study examined how six JAK inhibitors affect inflammatory, adhesion, coagulation, and apoptotic responses in human endothelial cells exposed to TNF and IL-17A. Its key contribution is showing that suppression of cytokine release does not necessarily normalize vascular dysfunction, and that inhibitor-specific and concentration-dependent effects may be important when interpreting cardiovascular safety.

• Polygodial: TRPA1 Channel Activation Workflows

  2026-08-16

  Polygodial provides a practical chemical handle for acute TRPA1 activation in calcium imaging, epithelial inflammatory signaling, and sensory biology assays. This workflow-focused guide connects controlled compound handling with the Ca2+/NFAT findings reported in nasal epithelial cells while emphasizing controls, dose-finding, and troubleshooting.

• AAL-993: Selective VEGF Receptor Inhibitor

  2026-08-15

  AAL-993 is a selective VEGF receptor inhibitor that targets VEGFR-1, VEGFR-2, and VEGFR-3. Its reported kinase potency, anti-angiogenic activity, and melanoma-model results support tumor angiogenesis research, but no clinical efficacy or safety conclusions are established.

• HSP90 Nanoparticles Enhance FMD CD8+ Immunity

  2026-08-14

  The reference study introduces HACC-TNF-α-VLP nanoparticles as a delivery system designed to overcome the weak cellular and mucosal immunity typically produced by foot-and-mouth disease virus-like particle vaccines. Its results connect nanoparticle uptake by dendritic cells with HSP90-dependent antigen cross-presentation, stronger CD8+ T-cell responses, tissue-resident memory formation, and secretory IgA production.

• Lopinavir: From HIV Potency to Assay Insight

  2026-08-14

  Lopinavir (ABT-378) offers a powerful framework for connecting biochemical HIV protease inhibition with cell-based antiviral interpretation. This article examines how its potency, serum behavior, resistance profile, and repurposing evidence should shape rigorous HIV and emerging-virus assays.

• Bleomycin Sulfate: Mechanism & Fibrosis Models

  2026-08-13

  Bleomycin Sulfate, also known as Blenoxane, is a metal-dependent DNA strand break inducer used in oncology and pulmonary fibrosis research. Its experimental value comes from reproducible genotoxic injury, but its IC50, exposure route, and disease-model interpretation remain context dependent.

15127 records 1/1009 page Next 12345 下5页 Last page